TuHURA Biosciences

TuHURA Biosciences

Developing personalized cancer vaccines to enhance immunotherapy effectiveness.

HQ location
Tampa, United States
Launch date
  • Edit
Get premium to view all results
DateInvestorsAmountRound
N/A

€0.0

round
*
N/A

$12.6m

Post IPO Equity
Total Funding000k
No items found
No investors found
Notes (0)
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Investments by TuHURA Biosciences

Edit
Kineta
ACQUISITION by TuHURA Biosciences Dec 2024
Cohbar
exited
Kintara Therapeutics
ACQUISITION by TuHURA Biosciences Apr 2024